E815
TEAS SECTION 8 & 15 RECEIVED
06/05/2026
Back to search
Official data from USPTO
QDB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/06/2026
Trademark type
Combined
Nice classes
1, 5, 42, 44
Filing date
01/26/2018
Registration date
04/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2021
Last transaction
06/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/04/2018
First use in commerce
09/04/2018
Drawing code
3
Owner type
03
Owner location
Chapel Hill, NC, US
Examiner
VOHRA, SANJEEV KUMAR
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "QDB", where the letter "Q" is designed as a magnifying glass encompassing the letters "DB".
Holders and representatives
Holders
Quanticision Diagnostics, Inc
Representatives
Quanticision Diagnostics, Inc
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; diagnostic preparations for scientific use; diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for scientific or research use; diagnostic reagents for scientific use; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Class 5
Diagnostic agentspreparations and substances for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents and media for medical and veterinary diagnostic purposes
Class 42
Computer diagnostic services; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; providing a website featuring information about investigational medical devicesdiagnostics and drugs; providing medical testing services and information in the field of cancer research and disease classification
Class 44
Consulting services in the fields of diagnostic medical testing and nutrition; health care servicesproviding a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes; providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
41 publications found
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/13/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/09/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/04/2021
IUAF
USE AMENDMENT FILED
02/22/2021
EISU
TEAS STATEMENT OF USE RECEIVED
02/22/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/19/2020
EX4G
SOU EXTENSION 4 GRANTED
09/18/2020
EXT4
SOU EXTENSION 4 FILED
08/20/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/20/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/06/2020
EX3G
SOU EXTENSION 3 GRANTED
03/05/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/05/2020
EXT3
SOU EXTENSION 3 FILED
02/24/2020
EEXT
SOU TEAS EXTENSION RECEIVED
02/24/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/24/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/27/2019
EX2G
SOU EXTENSION 2 GRANTED
08/24/2019
EXT2
SOU EXTENSION 2 FILED
08/24/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/24/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/28/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/26/2019
EX1G
SOU EXTENSION 1 GRANTED
02/26/2019
EXT1
SOU EXTENSION 1 FILED
02/26/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/26/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/28/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/03/2018
PUBO
PUBLISHED FOR OPPOSITION
07/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/13/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/17/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
05/16/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2018
DOCK
ASSIGNED TO EXAMINER
05/09/2018
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/08/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2018
NWAP
NEW APPLICATION ENTERED
01/30/2018
Continuous trademark protection
Get notified about every new filing that threatens QDB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.